Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

55.70
Delayed Data
As of Dec 12
 +0.76 / +1.38%
Today’s Change
37.90
Today|||52-Week Range
56.69
+45.01%
Year-to-Date

Today’s Trading

Previous close54.94
Today’s open55.45
Day’s range55.16 - 55.87
Volume9,860,720
Average volume (3 months)5,426,659
Market cap$95.6B
Data as of 4:01pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+13.52%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+2.20%
P/E ratio46.4
Price/Sales2.73
Price/Book3.94

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.04+0.05%
NVONovo Nordisk+0.90+1.72%
GSKGlaxoSmithKline+0.21+0.59%
BMYBristol-Myers Squibb+0.26+0.41%
Data as of 4:02pm ET, 12/12/2017

Financials

Next reporting dateJanuary 24, 2018
EPS forecast (this quarter)$0.73
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts